NSA, or chemically similar compounds, may be of value in the treatment of IL-1β-mediated conditions, such as PAPA and HS, and in diseases associated with NETosis, including vasculitis, SLE, and psoriasis. This evidence concerns the gene IL1B and psoriasis.